Five Dividend Kings to Buy Based on Billionaire Investors’ Sentiment

The dividend king from the healthcare sector that enjoys the most support from the billionaires we track is Johnson & Johnson (NYSE:JNJ). However, during the last quarter, the number of billionaires bullish on the drug manufacturer slid by four to eight, while the total value of their holdings amounted to $1.69 billion at the end of last year. Fisher Asset Management owns the largest position in Johnson & Johnson (NYSE:JNJ) among the funds we track, reporting 10.82 million shares worth $1.11 billion in its 13F filing for the end of December.

Follow Johnson & Johnson (NYSE:JNJ)

Last year Johnson & Johnson (NYSE:JNJ) raised the quarterly dividend to $0.75 from $0.70 and currently its stock sports a yield of 2.79%. The company is currently involved in a series of lawsuits related to its discontinued hysterectomy device that allegedly led to spreading uterine cancer. The company has settled most claims and is continuing talks on others, according to reports.